Carl J. Danzig
- Ophthalmology top 2%
- Radiology, Nuclear Medicine and Imaging top 10%
- Molecular Biology
- Genetics
- Oncology
- Co-authors
- Arshad M. KhananiAamir AzizChristina Y. WengJerry A. ShieldsCarol L. ShieldsSzilárd KissHormoz EhyaArman Mashayekhi
- Topics
- Retinal Diseases and Treatments (9 papers)Retinal and Optic Conditions (6 papers)Retinal Imaging and Analysis (6 papers)
- Journals
- SHILAP Revista de lepidopterologíaOphthalmologyInvestigative Ophthalmology & Visual Science
- Partner nations
- United StatesUnited KingdomHungary
In The Last Decade
Carl J. Danzig
19 papers receiving 416 citations
Hit Papers
Peers
Comparison fields: 5 of 44
- Ophthalmology 349
- Radiology, Nuclear Medicine and Imaging 193
- Molecular Biology 142
- Genetics 32
- Oncology 31
Countries citing papers authored by Carl J. Danzig
This map shows the geographic impact of Carl J. Danzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl J. Danzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl J. Danzig more than expected).
Fields of papers citing papers by Carl J. Danzig
This network shows the impact of papers produced by Carl J. Danzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl J. Danzig. The network helps show where Carl J. Danzig may publish in the future.
Co-authorship network of co-authors of Carl J. Danzig
This figure shows the co-authorship network connecting the top 25 collaborators of Carl J. Danzig. A scholar is included among the top collaborators of Carl J. Danzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl J. Danzig. Carl J. Danzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 29 | |
| 4 | 1 | |
| 5 | 16 | |
| 6 | 35 | |
| 7 | 0 | |
| 8 | The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month resultsbreakdown → | 90 |
| 9 | 80 | |
| 10 | 19 | |
| 11 | Real World Efficacy and Safety of Brolucizumab in Neovascular AMD: The REBEL Study | 8 |
| 12 | 33 | |
| 13 | Phase 1 Study of Intravitreal Gene Therapy with ADVM-022 for neovascular AMD (OPTIC Trial) | 15 |
| 14 | Clinical Effects of Blocking Ang-2 and VEGF with Faricimab in the Phase 2 STAIRWAY Trial | 1 |
| 15 | Efficacy and safety of faricimab every 16 or 12 weeks for neovascular age-related macular degeneration: STAIRWAY phase 2 results | 4 |
| 16 | 2 | |
| 17 | 10 | |
| 18 | 11 | |
| 19 | 5 | |
| 20 | 63 |
About Carl J. Danzig
Carl J. Danzig is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Dermatology, having authored 20 papers that have together received 425 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (9 papers), Retinal and Optic Conditions (6 papers) and Retinal Imaging and Analysis (6 papers). The work is most often cited by research in Ophthalmology (349 citations), Radiology, Nuclear Medicine and Imaging (193 citations) and Molecular Biology (142 citations). Carl J. Danzig has collaborated with scholars based in United States, United Kingdom and Hungary. Frequent co-authors include Arshad M. Khanani, Aamir Aziz, Christina Y. Weng, Jerry A. Shields, Carol L. Shields, Szilárd Kiss, Hormoz Ehya, Arman Mashayekhi, Peter K. Kaiser and Mathew Thomas. Their work appears in journals such as SHILAP Revista de lepidopterología, Ophthalmology and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.